31/12/2024
🎉 Wishing You a Happy New Year from Axio BioPharma! 🎉
As 2024 comes to a close, we reflect on the incredible milestones we’ve achieved since our launch in August. 🚀
✅ Established Our Laboratory: Our lab in Madison, WI is fully operational, supporting small-scale protein manufacturing projects.
✅ First Programs Initiated: We've begun generating real-world data through 96-well plate-based production, setting the foundation for our predictive AI model.
✅ Built a Stellar Team: Our growing team includes top talent, including Jaclyn Mabry and David Marshall, who are driving innovation in our lab. We also have the guidance of our amazing advisors: Dr. Greg Bleck, Dr. Graham Brearley, and Alex Vodenlich.
✅ Accelerated Services: Offering small-scale parallel manufacturing with a focus on mAbs, we’re delivering faster solutions with our 4 week gene-to-protein turnaround times.
✅ Set Our Vision: We’re transforming biopharmaceutical manufacturing with our proprietary AI model that predicts robust, scalable processes and reduces development timelines from years to hours.
We couldn’t have done this without the incredible support of our team, advisors, consultants, and the community. Here’s to a 2025 filled with growth, innovation, and breakthroughs in bringing life-saving therapies to patients faster.
Let’s keep accelerating together! 🚀✨
